Patent ID: 7585512

Claim:
A method of treating a malignant tumor in a human patient comprising co-administering to the patient (a) a composition comprising a therapeutically effective amount of human tumor cells that: (i) are conjugated to a hapten; (ii) are of the same tumor type as the malignant tumor of said patient for treatment of whom the composition is intended; (iii) are autologous to said patient; and (iv) have been rendered incapable of growing in the body of a human upon injection therein; and (b) an adjuvant; wherein said malignant tumor is from a cancer selected from the group consisting of melanoma cancer, lung cancer, colon cancer, breast cancer, kidney cancer, and prostate cancer; and wherein said administration elicits a delayed-type hypersensitivity response by said patient to tumor cells conjugated to said hapten; and repeating said administration.